329 related articles for article (PubMed ID: 33288687)
1. Clinically approved IVIg delivered to the hippocampus with focused ultrasound promotes neurogenesis in a model of Alzheimer's disease.
Dubey S; Heinen S; Krantic S; McLaurin J; Branch DR; Hynynen K; Aubert I
Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32691-32700. PubMed ID: 33288687
[TBL] [Abstract][Full Text] [Related]
2. Vasculotide restores the blood-brain barrier after focused ultrasound-induced permeability in a mouse model of Alzheimer's disease.
Lynch M; Heinen S; Markham-Coultes K; O'Reilly M; Van Slyke P; Dumont DJ; Hynynen K; Aubert I
Int J Med Sci; 2021; 18(2):482-493. PubMed ID: 33390817
[TBL] [Abstract][Full Text] [Related]
3. Analysis of focused ultrasound-induced blood-brain barrier permeability in a mouse model of Alzheimer's disease using two-photon microscopy.
Burgess A; Nhan T; Moffatt C; Klibanov AL; Hynynen K
J Control Release; 2014 Oct; 192():243-8. PubMed ID: 25107692
[TBL] [Abstract][Full Text] [Related]
4. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease.
Jordão JF; Ayala-Grosso CA; Markham K; Huang Y; Chopra R; McLaurin J; Hynynen K; Aubert I
PLoS One; 2010 May; 5(5):e10549. PubMed ID: 20485502
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil recruitment and leukocyte response following focused ultrasound and microbubble mediated blood-brain barrier treatments.
Poon C; Pellow C; Hynynen K
Theranostics; 2021; 11(4):1655-1671. PubMed ID: 33408773
[No Abstract] [Full Text] [Related]
6. Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound.
Jordão JF; Thévenot E; Markham-Coultes K; Scarcelli T; Weng YQ; Xhima K; O'Reilly M; Huang Y; McLaurin J; Hynynen K; Aubert I
Exp Neurol; 2013 Oct; 248():16-29. PubMed ID: 23707300
[TBL] [Abstract][Full Text] [Related]
7. Focused ultrasound-induced blood-brain barrier opening improves adult hippocampal neurogenesis and cognitive function in a cholinergic degeneration dementia rat model.
Shin J; Kong C; Lee J; Choi BY; Sim J; Koh CS; Park M; Na YC; Suh SW; Chang WS; Chang JW
Alzheimers Res Ther; 2019 Dec; 11(1):110. PubMed ID: 31881998
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound.
Rezai AR; Ranjan M; D'Haese PF; Haut MW; Carpenter J; Najib U; Mehta RI; Chazen JL; Zibly Z; Yates JR; Hodder SL; Kaplitt M
Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9180-9182. PubMed ID: 32284421
[TBL] [Abstract][Full Text] [Related]
9. Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease: long-term safety, imaging, and cognitive outcomes.
Rezai AR; Ranjan M; Haut MW; Carpenter J; D'Haese PF; Mehta RI; Najib U; Wang P; Claassen DO; Chazen JL; Krishna V; Deib G; Zibly Z; Hodder SL; Wilhelmsen KC; Finomore V; Konrad PE; Kaplitt M;
J Neurosurg; 2023 Jul; 139(1):275-283. PubMed ID: 36334289
[TBL] [Abstract][Full Text] [Related]
10. Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD model.
Kong C; Yang EJ; Shin J; Park J; Kim SH; Park SW; Chang WS; Lee CH; Kim H; Kim HS; Chang JW
Transl Neurodegener; 2022 Dec; 11(1):57. PubMed ID: 36575534
[TBL] [Abstract][Full Text] [Related]
11. Focused ultrasound with anti-pGlu3 Aβ enhances efficacy in Alzheimer's disease-like mice via recruitment of peripheral immune cells.
Sun T; Shi Q; Zhang Y; Power C; Hoesch C; Antonelli S; Schroeder MK; Caldarone BJ; Taudte N; Schenk M; Hettmann T; Schilling S; McDannold NJ; Lemere CA
J Control Release; 2021 Aug; 336():443-456. PubMed ID: 34186148
[TBL] [Abstract][Full Text] [Related]
12. Investigating the efficacy of a combination Aβ-targeted treatment in a mouse model of Alzheimer's disease.
Liu M; Jevtic S; Markham-Coultes K; Ellens NPK; O'Reilly MA; Hynynen K; Aubert I; McLaurin J
Brain Res; 2018 Jan; 1678():138-145. PubMed ID: 29066368
[TBL] [Abstract][Full Text] [Related]
13. Magnetic-resonance imaging for kinetic analysis of permeability changes during focused ultrasound-induced blood-brain barrier opening and brain drug delivery.
Chai WY; Chu PC; Tsai MY; Lin YC; Wang JJ; Wei KC; Wai YY; Liu HL
J Control Release; 2014 Oct; 192():1-9. PubMed ID: 24969355
[TBL] [Abstract][Full Text] [Related]
14. A sporadic Alzheimer's blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodies.
Wasielewska JM; Chaves JCS; Johnston RL; Milton LA; Hernández D; Chen L; Song J; Lee W; Leinenga G; Nisbet RM; Pébay A; Götz J; White AR; Oikari LE
Theranostics; 2022; 12(16):6826-6847. PubMed ID: 36276649
[No Abstract] [Full Text] [Related]
15. Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice.
Moon M; Cha MY; Mook-Jung I
J Alzheimers Dis; 2014; 41(1):233-41. PubMed ID: 24583405
[TBL] [Abstract][Full Text] [Related]
16. Quantification of transient increase of the blood-brain barrier permeability to macromolecules by optimized focused ultrasound combined with microbubbles.
Shi L; Palacio-Mancheno P; Badami J; Shin DW; Zeng M; Cardoso L; Tu R; Fu BM
Int J Nanomedicine; 2014; 9():4437-48. PubMed ID: 25258533
[TBL] [Abstract][Full Text] [Related]
17. Natural aging and Alzheimer's disease pathology increase susceptibility to focused ultrasound-induced blood-brain barrier opening.
Noel RL; Batts AJ; Ji R; Pouliopoulos AN; Bae S; Kline-Schoder AR; Konofagou EE
Sci Rep; 2023 Apr; 13(1):6757. PubMed ID: 37185578
[TBL] [Abstract][Full Text] [Related]
18. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.
Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272
[TBL] [Abstract][Full Text] [Related]
19. Targeted drug delivery with focused ultrasound-induced blood-brain barrier opening using acoustically-activated nanodroplets.
Chen CC; Sheeran PS; Wu SY; Olumolade OO; Dayton PA; Konofagou EE
J Control Release; 2013 Dec; 172(3):795-804. PubMed ID: 24096019
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood-brain barrier opening for enhanced temozolomide delivery in glioma treatment.
Liu HL; Huang CY; Chen JY; Wang HY; Chen PY; Wei KC
PLoS One; 2014; 9(12):e114311. PubMed ID: 25490097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
